This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The contract has a period of performance through March 31, 2025. Inflammatix has a history of federal contract and grant awards from HHS agencies, including over $29 million in support for the development of other diagnostic solutions for acute infections, sepsis, and COVID-19.
Generated 6/19/24, 10:03 AM